The head of the Food and Drug Administration’s drug center abruptly resigned Sunday amid concerns about his personal conduct.
The US Food and Drug Administration’s lead drug regulator George Tidmarsh resigned two days after being placed on ...
Dr. George Tidmarsh, the Food and Drug Administration’s top drug regulator, was placed on administrative leave and is ...
The U.S. Food and Drug Administration announced it will relax certain rules for approving low-cost versions of some ...
The U.S. Food and Drug Administration says drug makers have recalled more than a half-million bottles of the blood pressure ...
George Tidmarsh, the FDA's top drug regulator, has been placed on leave after being accused of abusing his regulatory ...
The U.S. Food and Drug Administration (FDA) announced that more than 580,000 bottles of the blood pressure medication prazosin hydrochloride ...
The U.S. Food and Drug Administration said on Friday it warned four companies that it plans to take enforcement action over ...
The Trump administration is proposing changes to Food and Drug Administration guidelines that would make it less expensive ...
Eli Lilly is partnering with Walmart to offer Zepbound through its direct-to-consumer program, making the popular medication ...
Successful completion of first trial phase enables continued pivotal trial of FemBloc, the only non-surgical permanent birth control, toward U.S. FDA approval -- -- $12 million senior secured ...